Files in This Item:


Title: Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine
Authors: Shibl, A.
Tufenkeji, H.
Khalil, M.
Memish, Z.
Issue Date: 2013
Language: English
Abstract: The Islamic Hajj to Makkah [Mecca] has been associated with outbreaks of invasive meningpcoccal disease and the global spread of Neisseria Heningitidis serogroup W-135. For Hajj pilgrims the quadrivalent vaccination against serogroups A, C, W-135 and Y is a mandatory requirement. Novel conjugate vaccines may provide benefits for the community by reduction of carriage. With the introduction of the new generation of quadrivalent meningococcal conjugate vaccines [Menveo, Menactra, and other pending license] and their recent implementation in Saudi Arabia, experts from 11 countries in the Middle East region met at a Meningococcal Leadership Forum [MLF], in Dubai in May 2010 to exchange opinions on meningococcal disease and prevention strategies. These experts discussed the importance of introducing conjugate vaccines for pilgrims and travellers, and elaborated a consensus recommendation to support healthcare professionals and decision-makers
Description: 389 - 392
Keywords: Consensus
Travel Medicine
Neisseria meningitidis
Vaccines, Conjugate
Subject: Meningococcal Infections
ISSN: 1020-3397
Other Identifiers:
Appears in Collections:EMRO Journal Articles (EMHJ)

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.